Streetbeat News

Stock Prices

PSX

Investors with significant funds have taken a bullish position in Phillips 66 (NYSE:PSX), as identified by Benzinga's options scanner. The sentiment among these large-scale traders is mixed, with 50% being bullish and 37% bearish. The options data shows a price range target from $105.0 to $155.0 for PSX over the last 3 months. Analysts have issued positive ratings with a consensus target price of $165.0.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 4:36 pm

TXN

Market whales have taken a bearish position on Texas Instruments (NASDAQ:TXN), with 40% of the options transactions being bearish. The average price target from analysts is $182.0, with mixed ratings. The stock is currently trading at $194.84, down by -0.04%.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 4:35 pm

BRKR

Bruker Corp (NASDAQ:BRKR) shares are down 6.6% to $67.80 after announcing a public offering of 6 million shares, with an option for underwriters to purchase an additional 900,000 shares. The proceeds will be used to reduce debt from recent acquisitions.

Portfolio Pulse from Henry Khederian

May 30, 2024 | 4:35 pm

BBW

FFIE

FTEL

JFBR

KAVL

KSS

LITB

NAAS

RENT

SERV

WOOF

The article highlights significant intraday movements in consumer discretionary stocks. Faraday Future, Petco Health and Wellness, Jeffs Brands, Foot Locker, Rent the Runway, and Serve Robotics saw notable gains, while Kohl's, LightInTheBox Holding, Kaival Brands Innovations, Naas Technology, Build-A-Bear Workshop, and Fitell experienced declines. Earnings reports were a key driver for several stocks.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 4:33 pm

BSGM

DARE

HLTH

ISPC

KTRA

LEXX

LUCY

MIRA

ONMD

RSLS

SNOA

XERS

The article highlights the intraday movements of 12 health care stocks on Thursday. Notable gainers include Cue Health (HLTH), OneMedNet (ONMD), iSpecimen (ISPC), Xeris Biopharma Holdings (XERS), Kintara Therapeutics (KTRA), and Lexaria Bioscience (LEXX). Significant losers include Sonoma Pharmaceuticals (SNOA), BioSig Technologies (BSGM), Mira Pharmaceuticals (MIRA), Innovative Eyewear (LUCY), Reshape Lifesciences (RSLS), and Dare Bioscience (DARE).

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 4:32 pm

AMSC

AWIN

FLYX

FWRD

GETR

GVH

JCSE

KITT

MNTS

NNE

PEGY

SKYH

The article highlights the intraday movements of various industrial stocks on Thursday. JE Cleantech Holdings, Momentus, American Superconductor, AERWINS Technologies, Nano Nuclear Energy, and Forward Air saw significant gains, while flyExclusive, Pineapple Energy, Nauticus Robotics, Sky Harbour Group, Globavend Holdings, and Getaround experienced notable declines.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 4:32 pm

CETX

CRDO

CRM

HPQ

MAXN

NTNX

PATH

SGE

SOBR

SONM

TRSG

The article highlights the intraday movements of various Information Technology stocks on Thursday. Notable gainers include Cemtrex, Sobr Safe, Credo Technology Group, HP, Sonim Technologies, and C3.ai. Significant losers include UiPath, Maxeon Solar Technologies, Tungray Technologies, Strong Global, Nutanix, and Salesforce.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 4:32 pm

ONMD

OneMedNet Corp (NASDAQ:ONMD) shares surged after announcing a three-year Master Services Agreement with a major U.S.-based medical technology company. The agreement involves using OneMedNet's iRWD platform to manage clinical data for over 150 million patients annually. Despite the recent gains, ONMD has lost 71.95% year to date and shows overbought conditions with an RSI of 79.7.

Portfolio Pulse from Erica Kollmann

May 30, 2024 | 4:30 pm

Deere (NYSE:DE) has outperformed the market over the past 5 years with an average annual return of 20.22%, significantly boosting investor returns. A $1000 investment in DE stock 5 years ago would now be worth $2,552.17.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 4:30 pm

Trane Technologies (NYSE:TT) has significantly outperformed the market over the past 10 years, delivering an average annual return of 21.43%. A $100 investment in TT stock 10 years ago would now be worth $706.43, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 4:30 pm